Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.31 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.31 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26430746 | 1.00 | L3MBTL1 (0.36) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL26430755 | 0.97 | MEN1 (0.34) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL26430764 | 0.97 | ALDH1A1 (0.34) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL26430749 | 0.96 | MEN1 (0.34) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL26430771 | 0.96 | KDM4E (0.36) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL26430776 | 0.95 | MEN1 (0.32) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL26430752 | 0.94 | SIRT2 (0.33) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL26430772 | 0.94 | MEN1 (0.34) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL31771 | 0.93 | KDM4E (0.37) | L3MBTL1KDM4EATMALDH1A1KMT2A | |
| SCHEMBL23597939 | 0.93 | PLA2G2A (0.32) | L3MBTL1KDM4EATMALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230130126-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230130126-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230130126-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | CRY1, PER2, CRY2 | L3MBTL1 1569/4885KDM4E 2784/4885ATM 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.